Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 12, 2002, Pages 2054-2058

  Engström, Gunnar ^a   Janzon, Lars ^a   Berglund, Göran ^a   Lind, Peter ^a   Stavenow, Lars ^a   Hedblad, Bo ^a   Lindgärde, Folke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Hypertension; Inflammation

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID; PLASMA PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CERULOPLASMIN BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTHESIS; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PROTEINS; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SYSTOLE;

EID: 0036920207     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000041842.43905.F3     Document Type: Article

References (24)

1. Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgärde F. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: A long-term cohort study. Arlerioscler Thromb Vasc Biol. 2001;21:452-458.
2. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403.
3. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk, factors in apparently healthy men. Am J Cardiol. 1999:84:1018-1022.
4. Yudkin JS. Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arlerioscler Thromb Vasc Biol. 1999;19:972-978.
5. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol. 2001;153:1183-1190.
6. Friedman GD, Selby JV, Quesenberry CP Jr. The leukocyte count: A predictor of hypertension. J Clin Epidemiol. 1990;43:907-911.
7. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002;105:2632-2637.
8. Berglund G, Nilsson P, Eriksson KF, Nilsson JÅ, Hedblad B, Kristenson H. Lindgärde F. Long-term outcome of the Maimö preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247:19-29.
9. Berglund G. Elmståhl S, Janzon L, Larsson SA. Design and feasibility. J Intern Med, 1993:233:45-51.
10. Wallström P, Wirfält E, Lahmann PH, Gullberg B, Janzon L, Berglund G. Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr. 2001;73:777-785.
11. Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest Suppl 1972;124:21-37.
12. World Health Organization. Guidelines for the treatment of mild hypertension: Memorandum from a WHO/ISH meeting, J Hypertens. 1986;1986:4:383-386.
13. Mendall MA, Strachan DP, Butland BK. Ballam L, Morris J, Sweetnam PM. Elwood PC, C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584-1590.
14. Lagrand WK, Visser CA, Hermens WT. Niessen HW,. Verheugt FW,. Wolbink GJ, Hack CE. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation, 1999;100:96-102
15. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
16. Dart AM, Kingwell BA. Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001:37:975-984.
17. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
18. Robbie L, Libby P, Inflammation and atherosclerosis. Ann N YAcad Sci. 2001;947:167-180.
19. Mancia G, Parati G, Di Rienzo M. Zanchetti A. Blood pressure variability In: Zanchetti A, Mancia G, eds. Handbook of Hypertension: Pathophysiology of Hypertension. Vol. 17. Amsterdam: Elsevier Science; 1997:117-169.
20. Jamerson K, Julius S, Predictors of blood pressure and hypertension: General principles. Am J Hypertens. 1991;4:598S-602S.
21. Horan MJ, Lenfant C. Epidemiology of blood pressure and predictors of hypertension. Hypertension. 1990:15(suppl I):I20-I24.
22. , Levenstein S. Smith MW, Kaplan GA. Psychosocial predictors of hypertension in men and women. Arch Intern Med. 2001:161:1341-1346.
23. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17: Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension. 200;36:477-483.
24. Omvik P, How smoking affects blood pressure, Blood Pressure, 1996;5:71-77.